Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Kodiak Sciences Inc
KOD | US
2.49
USD-0.17
-6.39%
KOD | US
About Kodiak Sciences Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/09/2023
As of date
29/11/2023
Close
2.49
Open
2.65
High
2.75
Low
2.46
Kodiak Sciences Inc. a clinical stage biopharmaceutical company researches develops and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301) an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD) as well as Phase III clinical study for the treatment of diabetic macular edema naïve macular edema due to retinal vein occlusion and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501 a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601 a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto California.
View LessKOD | US
Risk
187.6%
Sharpe
-0.67
Luna's Score
43/100
Recommendation
Sell
Luna says (KOD | US)
What's Working
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
No Dividends (Dividend Yield = 0%)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
179.6%1 month
187.6%3 months
125.1%6 months
128.8%Return
Fundamental Ratios
PE
0
Fwd. PE
0
Price to book
0.80
Debt to equity
0.28
Debt to assets
0.15
Ent. to EBITDA
0.20
Ent. to rev.
0
PEG
0
Other Fundamentals
EBITDA
-272.88M
MarketCap
130.66M
MarketCap(USD)
130.66M
Div. yield
0
Op. margin
0
Erngs. growth
0
Rev. growth
0
Ret. on equity
-69.42
Short ratio
7.62
Short perc.
9.74
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.90
Range1M
1.38
Range3M
1.39
Volumes: Market Activity
Rel. volume
0.44
Price X volume
1.86M
